The role of nuclear medicine in liver imaging has greatly changed over
the last decade. This change has involved a switch from a general hep
atic imaging method Loa very niche role, with imaging agents and metho
ds directed toward very specific clinical problems and conditions. Nuc
lear medicine imaging equipment has also continued to evolve. This art
icle addresses the roles of radiolabled octreotide imaging, monoclonal
antibody imaging, and fluorodeoxyglucose imaging.